[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:intermittent-claudication":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Intermittent claudication",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06657976","Response to Exercise and Nitric Oxide in PAD",[11],"Phase 2","RECRUITING","2026-08-26T02:19:04.543908Z","2026-07-30T01:46:14.467051Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05132439","MetfOrmin BenefIts Lower Extremities With Intermittent Claudication",[19],"Phase 3","2026-08-26T02:19:17.380174Z","2026-05-05T02:43:27.624220Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT03203239","Red Light Treatment in Peripheral Artery Disease",[],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:27.669071Z",[],[]]